Northeast Investment Management Cut Johnson & Johnson (JNJ) Position; CRITICAL ELEMENTS COMPANY (CRECF) Shorts Down By 10%

January 14, 2018 - By Clifton Ray

CRITICAL ELEMENTS COMPANY (OTCMKTS:CRECF) had a decrease of 10% in short interest. CRECF’s SI was 11,700 shares in January as released by FINRA. Its down 10% from 13,000 shares previously. With 50,900 avg volume, 0 days are for CRITICAL ELEMENTS COMPANY (OTCMKTS:CRECF)’s short sellers to cover CRECF’s short positions. The stock decreased 2.29% or $0.0291 during the last trading session, reaching $1.2409. About 2,501 shares traded. Critical Elements Corporation (OTCMKTS:CRECF) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Northeast Investment Management decreased Johnson & Johnson (JNJ) stake by 1.56% reported in 2017Q3 SEC filing. Northeast Investment Management sold 4,005 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Northeast Investment Management holds 252,881 shares with $32.88M value, down from 256,886 last quarter. Johnson & Johnson now has $391.59B valuation. The stock increased 0.67% or $0.97 during the last trading session, reaching $145.76. About 5.45 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 14, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Critical Elements Corporation, a junior mining company, acquires, explores, and develops mining properties in Canada. The company has market cap of $185.72 million. It primarily explores for copper, zinc, gold, silver, nickel, lead, lithium, niobium, tantalum, and platinum group elements. It currently has negative earnings. The Company’s flagship project is the Rose lithium-tantalum property that consists of 500 claims covering a total area of 260.90 square kilometers, located in the Eastmain greenstone belt.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62 billion for 21.19 P/E if the $1.72 EPS becomes a reality. After $1.90 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It has no change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Burns J W Com Incorporated New York owns 2.01% invested in Johnson & Johnson (NYSE:JNJ) for 57,973 shares. Moreover, Lombard Odier Asset (Switzerland) Sa has 2.11% invested in Johnson & Johnson (NYSE:JNJ) for 167,045 shares. Parametric Port Assoc Ltd Limited Liability Company accumulated 8.03 million shares or 1.16% of the stock. Brinker Capital accumulated 86,916 shares or 0.47% of the stock. Caisse De Depot Et Placement Du Quebec holds 5.69 million shares. Wetherby Asset Management stated it has 61,751 shares or 1.19% of all its holdings. Peddock Capital Advsr Ltd reported 0.57% of its portfolio in Johnson & Johnson (NYSE:JNJ). 21,656 are held by Moneta Investment Advsr Lc. Argi Invest Svcs Lc reported 0.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). 154,191 were accumulated by Amica Mutual Insur. Private Trust Na stated it has 1.42% in Johnson & Johnson (NYSE:JNJ). Penobscot Management Inc holds 74,690 shares. Moreover, Farmers Tru has 3.36% invested in Johnson & Johnson (NYSE:JNJ) for 76,662 shares. Continental Advisors Ltd Liability holds 0.22% or 7,300 shares in its portfolio. Mogy Joel R Counsel Inc owns 180,081 shares or 3.89% of their US portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News